Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor (NCT03158688)

Saad Z. Usmani, MDMBBS, Hang Quach, MD, María-Victoria Mateos, Ola Landgren, MD PhD, Xavier Leleu, MD PhD, David S. Siegel, Katja Weisel, Hui Yang, Zandra K. Klippel, MD, Anita Zahlten-Kumeli, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_2): LBA-6.

https://doi.org/10.1182/blood-2019-132629

Published: 2019

Journal Articles

Value of Incorporating Newly Identified Risk Factors into Risk Prediction for Chemotherapy-Induced Febrile Neutropenia (FN)

Yanli Li, MD PhD, Leila Family, PhD, Lie Hong Chen, DrPH, John H. Page, MD ScD, Zandra K. Klippel, MD, Lanfang Xu, PhD, Chun Chao, PhD

Blood (2016) 128 (22): 4797.

https://doi.org/10.1182/blood.V128.22.4797.4797

Published: 2016

Journal Articles

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Yanli Li, MDPhD, Xiaolong Shih, PhD, Zandra K. Klippel, MD, Maureen Reiner, M.S., John H Page, MD ScD

Blood (2014) 124 (21): 4960.

https://doi.org/10.1182/blood.V124.21.4960.4960

Published: 2014

Journal Articles

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Colin Phipps, MD, Michael L. Linenberger, MD, Damian J. Green, MD, M. Corinna Palanca-Wessels, MD, PhD, Pamela S. Becker, MD, PhD, Laura S. Connelly-Smith, MBBCh, DM, Nicholas Burwick, MD, Zandra K. Klippel, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 4507.

https://doi.org/10.1182/blood.V122.21.4507.4507

Published: 2013

Journal Articles

Preclinical Evaluation Of Engineered T Cells In Multiple Myeloma: Uncovering a Mechanism Of Immune Escape

Zandra K. Klippel, MD, Jeffrey Chou, MD, PhD, Andrea M. H. Towlerton, Paul F Robbins, PhD, Lilien Voong, William I. Bensinger, MD, H. Lokhorst, Tuna Mutis, MD, PhD, Lihua Elizabeth Budde, MD, PhD, Edus H. Warren, III, MD, PhD

Blood (2013) 122 (21): 4205.

https://doi.org/10.1182/blood.V122.21.4205.4205

Published: 2013

Journal Articles

Epigenetic Regulation of Cancer-Testis Antigen Expression in Multiple Myeloma and Correlation with High-Risk Cytogenetics.

Zandra K. Klippel, MD, Akshay Srivatsan, Andrea M. H. Towlerton, Jeffrey Chou, MD, PhD, Tuna Mutis, MD PhD, Henk Lokhorst, William I. Bensinger, MD, Edus H. Warren, III, MD, PhD

Blood (2012) 120 (21): 2923.

https://doi.org/10.1182/blood.V120.21.2923.2923

Published: 2012

Journal Articles

Improved Stem Cell Transplant Related Mortality for AL Amyloidosis At a Single Transplant Center

Zandra K. Klippel, MD, Barry Storer, PhD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Pamela S Becker, MD, PhD, Damian J. Green, MD, Nicholas Burwick, MD, Edward N. Libby, III, MD

Blood (2012) 120 (21): 2016.

https://doi.org/10.1182/blood.V120.21.2016.2016

Published: 2012

NARROW

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor (NCT03158688)

Value of Incorporating Newly Identified Risk Factors into Risk Prediction for Chemotherapy-Induced Febrile Neutropenia (FN)

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Preclinical Evaluation Of Engineered T Cells In Multiple Myeloma: Uncovering a Mechanism Of Immune Escape

Epigenetic Regulation of Cancer-Testis Antigen Expression in Multiple Myeloma and Correlation with High-Risk Cytogenetics.

Improved Stem Cell Transplant Related Mortality for AL Amyloidosis At a Single Transplant Center

Email alerts

ASH Publications

American Society of Hematology

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor (NCT03158688)

Value of Incorporating Newly Identified Risk Factors into Risk Prediction for Chemotherapy-Induced Febrile Neutropenia (FN)

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Preclinical Evaluation Of Engineered T Cells In Multiple Myeloma: Uncovering a Mechanism Of Immune Escape

Epigenetic Regulation of Cancer-Testis Antigen Expression in Multiple Myeloma and Correlation with High-Risk Cytogenetics.

Improved Stem Cell Transplant Related Mortality for AL Amyloidosis At a Single Transplant Center

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only